Gilead's Daniel O'Day relishes Dietmar Berger reunion as cancer specialist agrees to join from Sanofi.

Authors :: Taylor, Nick Paul
Source :: FierceBiotech; 12/13/2024, pN.PAG-N.PAG, 1p
Publication Year :: 2024
Abstract: Dietmar Berger's appointment reunites Gilead CEO Daniel O'Day with a key member of the oncology team from his time at Roche. [ABSTRACT FROM AUTHOR]

Subjects :: ONCOLOGISTS
EXECUTIVES
CHIEF executive officers
REUNIONS
ONCOLOGY

Tools